强化胰岛素治疗对新诊断的2型糖尿病患者的β细胞功能和血糖控制的影响:多中心随机并行组试验
Jianping Weng1, Yanbing Li, Wen Xu
1Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. wjianp@mail.sysu.edu.cn
Lancet (London, England)
|May 27, 2008
概括
早期的强化胰岛素治疗,包括持续的皮下胰岛素输注 (CSII) 或每天多次注射 (MDI),显著改善β细胞功能,并与口服药物相比,实现更高的糖尿病缓解率.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 糖尿病研究 糖尿病研究
背景情况:
- 新诊断的2型糖尿病 (T2D) 管理对于长期结果至关重要.
- 早期的密集干预可以增强β细胞功能,并延长血糖缓解.
- 将胰岛素治疗与口服药物进行比较对于优化T2D治疗策略至关重要.
研究的目的:
- 在新诊断的T2D患者中,比较过渡性强化胰岛素治疗 (CSII或MDI) 与口服低血糖药物 (OHA) 的疗效.
- 评估这些疗法对β细胞功能和血糖缓解率的影响.
- 评估治疗效果在1年随访后的持久性.
主要方法:
- 一个多中心的随机试验,涉及382名T2D患者,其禁食血葡萄糖在7.0-16.7 mmol/L之间.
- 患者接受了初始强化胰岛素 (CSII/MDI) 或OHA治疗,以快速纠正高血糖症.
- 在2周的正常血糖症后,治疗被取消,随后进行生活方式干预和1年的随访,对β细胞功能进行评估.
主要成果:
- 与OHA组相比,胰岛素组 (CSII/MDI) 实现了目标血糖控制的速度更快,并且患者的百分比更高.
- 一年缓解率在CSII (51.1%) 和MDI (44.9%) 组明显高于OHA组 (26.7%).
- 通过HOMA-B和急性胰岛素反应表明的β细胞功能,在胰岛素治疗后显著改善,并在1年内持续.
结论:
- 早期的强化胰岛素治疗在新诊断的T2D患者中显示出优异的结果.
- 胰岛素治疗促进β细胞的恢复和维护,导致长时间的血糖缓解.
- 过渡性强化胰岛素治疗提供了一个比口服药物更有效的策略来管理T2D.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
